These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 12618251

  • 1. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.
    Oral Contraceptive and Hemostasis Study Group.
    Contraception; 2003 Mar; 67(3):173-85. PubMed ID: 12618251
    [Abstract] [Full Text] [Related]

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 3. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Mar; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

  • 4. An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
    Contraception; 1999 Jun; 59(6):345-55. PubMed ID: 10518228
    [Abstract] [Full Text] [Related]

  • 5. Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Klipping C, Duijkers I, Parke S, Mellinger U, Serrani M, Junge W.
    Drugs R D; 2011 Jun; 11(2):159-70. PubMed ID: 21679006
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 7. An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
    Winkler UH, Röhm P, Höschen K.
    Contraception; 2010 May; 81(5):391-400. PubMed ID: 20399945
    [Abstract] [Full Text] [Related]

  • 8. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 9. Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study.
    Peters K, Gordon N, Ricciotti N, Hsieh J, Howard B, Weiss H.
    Clin Exp Obstet Gynecol; 2016 Aug; 43(3):334-40. PubMed ID: 27328486
    [Abstract] [Full Text] [Related]

  • 10. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 11. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J, Feichtinger W, Kindermann C, Schneider B, Mellinger U, Walter F, Moore C, Gräser T.
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 14. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 15. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
    Nappi RE, Paoletti AM, Volpe A, Chiovato L, Howard B, Weiss H, Ricciotti N.
    Eur J Contracept Reprod Health Care; 2014 Aug; 19(4):285-94. PubMed ID: 24923685
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgram levonorgestrel.
    Winkler UH, Howie H, Bühler K, Korver T, Geurts TB, Coelingh Bennink HJ.
    Contraception; 1998 Jun; 57(6):385-92. PubMed ID: 9693398
    [Abstract] [Full Text] [Related]

  • 17. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 19. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 20. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun 10; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.